Skip to main content

Table 1 Baseline characteristics of HCC patients treated by cTACE with CBCT assistance (CBCT-cTACE) and patients treated by cTACE with DSA alone (DSA-cTACE)

From: Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization

Prognostic factors

CBCT-cTACE

n = 196

DSA-cTACE

n = 141

p value

Age, years, mean (range)

62.3 (21‒91)

63.3 (37‒90)

0.407

 Gender

 Male

140 (71)

94 (67)

0.414

 Female

56 (29)

47 (33)

 

Alcohol drinking

 No

164 (84)

119 (84)

0.978

 Yes

32 (16)

22 (16)

 

Hepatitis B virus carrier

 No

99 (51)

76 (54)

0.614

 Yes

97 (49)

65 (46)

 

Hepatitis C virus carrier

 No

142 (72)

105 (75)

0.773

 Yes

54 (28)

36 (25)

 

Child–Pugh Class

 A (5‒6)

144 (73)

96 (68)

0.283

 B (7)

37 (19)

27 (19)

 

 B (8‒9)

15 (8)

18 (13)

 

ALBI score

 1

53 (27)

35 (25)

0.780

 2

131 (67)

95 (67)

 

 3

12 (6)

11 (8)

 

Total bilirubin, (mg/dl), median (range)

0.87 (0.18‒2.87)

0.98 (0.20‒2.95)

0.154

Albumin, (ng/ml), median (range)

3.6 (2.2‒4.7)

3.4 (1.8‒4.8)

0.064

INR, median (range)

1.25 (1.0‒2.2)

1.22 (0.9‒2.0)

0.052

Platelet count, × 103/mm3, median (range)

99 (30‒435)

106 (35‒318)

0.853

Serum AFP level (ng/ml)

 < 20

96 (49)

56 (40)

0.241

 20‒200

57 (29)

48 (34)

 

 > 200

43 (22)

37 (26)

 

Ascites

 No

173 (88)

117 (83)

0.222

 Yes

23 (12)

24 (17)

 

Size of largest tumor, mm, median (range)

3.1 (1.1‒7.0)

3.2 (1.1‒7.0)

0.157

Tumor number

 1

108 (55)

72 (51)

0.179

 2–3

64 (33)

58 (41)

 

 4–5

24 (12)

11 (8)

 

Site of tumors

 Unilobar

165 (84)

118 (84)

1.000

 Bilobar

31 (16)

23 (16)

 

Up-to-7 criteria

 Within

158 (81)

109 (77)

0.547

 Beyond

38 (19)

32 (23)

 

BCLC-staging

 Stage A

115 (59)

71 (50)

0.130

 Stage B

81 (41)

70 (50)

 
  1. Data are presented as number (%) unless otherwise indicated
  2. CBCT-cTACE cone-beam computed tomography assisted conventional transarterial chemoembolization, DSA-cTACE digital subtraction angiography assisted conventional transarterial chemoembolization, ALBI albumin-bilirubin, INR international normalized ratio, AFP alpha-fetoprotein, BCLC Barcelona Clinic Liver Cancer